These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

702 related articles for article (PubMed ID: 18992314)

  • 1. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products.
    Pardeike J; Hommoss A; Müller RH
    Int J Pharm; 2009 Jan; 366(1-2):170-84. PubMed ID: 18992314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanostructured lipid carriers (NLC) in cosmetic dermal products.
    Müller RH; Petersen RD; Hommoss A; Pardeike J
    Adv Drug Deliv Rev; 2007 Jul; 59(6):522-30. PubMed ID: 17602783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cosmetic features and applications of lipid nanoparticles (SLN, NLC).
    Souto EB; Müller RH
    Int J Cosmet Sci; 2008 Jun; 30(3):157-65. PubMed ID: 18452432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid nanoparticles for improved topical application of drugs for skin diseases.
    Schäfer-Korting M; Mehnert W; Korting HC
    Adv Drug Deliv Rev; 2007 Jul; 59(6):427-43. PubMed ID: 17544165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy.
    Lombardi Borgia S; Regehly M; Sivaramakrishnan R; Mehnert W; Korting HC; Danker K; Röder B; Kramer KD; Schäfer-Korting M
    J Control Release; 2005 Dec; 110(1):151-63. PubMed ID: 16297487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid nanoparticles for parenteral delivery of actives.
    Joshi MD; Müller RH
    Eur J Pharm Biopharm; 2009 Feb; 71(2):161-72. PubMed ID: 18824097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).
    Fang JY; Fang CL; Liu CH; Su YH
    Eur J Pharm Biopharm; 2008 Oct; 70(2):633-40. PubMed ID: 18577447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals.
    Puglia C; Bonina F
    Expert Opin Drug Deliv; 2012 Apr; 9(4):429-41. PubMed ID: 22394125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations.
    Müller RH; Radtke M; Wissing SA
    Adv Drug Deliv Rev; 2002 Nov; 54 Suppl 1():S131-55. PubMed ID: 12460720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion.
    Huang ZR; Hua SC; Yang YL; Fang JY
    Acta Pharmacol Sin; 2008 Sep; 29(9):1094-102. PubMed ID: 18718178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid lipid nanoparticles for parenteral drug delivery.
    Wissing SA; Kayser O; Müller RH
    Adv Drug Deliv Rev; 2004 May; 56(9):1257-72. PubMed ID: 15109768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance.
    Mitri K; Shegokar R; Gohla S; Anselmi C; Müller RH
    Int J Pharm; 2011 Jul; 414(1-2):267-75. PubMed ID: 21596122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes.
    Souto EB; Müller RH
    Handb Exp Pharmacol; 2010; (197):115-41. PubMed ID: 20217528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy.
    Saupe A; Gordon KC; Rades T
    Int J Pharm; 2006 May; 314(1):56-62. PubMed ID: 16574354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery.
    Souto EB; Wissing SA; Barbosa CM; Müller RH
    Int J Pharm; 2004 Jun; 278(1):71-7. PubMed ID: 15158950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry.
    Castelli F; Puglia C; Sarpietro MG; Rizza L; Bonina F
    Int J Pharm; 2005 Nov; 304(1-2):231-8. PubMed ID: 16188405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.
    Attama AA; Schicke BC; Paepenmüller T; Müller-Goymann CC
    Eur J Pharm Biopharm; 2007 Aug; 67(1):48-57. PubMed ID: 17276663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanostructured lipid carriers system: recent advances in drug delivery.
    Iqbal MA; Md S; Sahni JK; Baboota S; Dang S; Ali J
    J Drug Target; 2012 Dec; 20(10):813-30. PubMed ID: 22931500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin permeation of buprenorphine and its ester prodrugs from lipid nanoparticles: lipid emulsion, nanostructured lipid carriers and solid lipid nanoparticles.
    Wang JJ; Liu KS; Sung KC; Tsai CY; Fang JY
    J Microencapsul; 2009 Dec; 26(8):734-47. PubMed ID: 19888882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of modified lipid nanoparticles for doxorubicin controlled release.
    Ying XY; Du YZ; Chen WW; Yuan H; Hu FQ
    Pharmazie; 2008 Dec; 63(12):878-82. PubMed ID: 19177903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.